Anticonvulsant mood stabilizers, antipsychotic drugs and the insulin resistance syndrome

Trial Profile

Anticonvulsant mood stabilizers, antipsychotic drugs and the insulin resistance syndrome

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Dec 2016

At a glance

  • Drugs Antipsychotics; Aripiprazole; Mood stabilisers; Ziprasidone
  • Indications Bipolar disorders; Schizoaffective disorder; Schizophrenia
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Jan 2009 Status changed from suspended to completed, based on information from ClinicalTrials.gov.
    • 12 Aug 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Jun 2008 Pfizer reported as trial affiliate by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top